PCA2- IRINOTECAN IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER- IMPROVED SURVIVAL AND COST EFFECTIVENESS COMPARED WITH INFUSIONAL 5-FLUOROURACIL
Abstract
Authors
DL Jackson A Burrell
DL Jackson A Burrell
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now